Dr. Willmar Schwabe GmbH & Co. KG — China drug registrations and re-registration deadlines
4 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2029-06-30.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20140768 | Ginaton 银杏叶提取物片 | 2029-12-30 | 2029-06-30 |
| 国药准字HJ20170088 | Ginaton 银杏叶提取物片 | 2029-12-30 | 2029-06-30 |
| 国药准字HJ20140770 | Ginaton 银杏叶提取物滴剂 | 2030-01-05 | 2029-07-05 |
| 国药准字ZJ20130002 | 马栗种子提取物片 | 2030-10-27 | 2030-04-27 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.